A model of the COVID-19 virus displayed at the National Institutes of Health, Thursday, Feb. 11, 2021, in Bethesda, Md. AP/Evan Vucci

A model of the COVID-19 virus displayed at the National Institutes of Health, Thursday, Feb. 11, 2021, in Bethesda, Md. AP/Evan Vucci

Here are 5 projects by companies tackling COVID-19 to watch in Canada

Provinces are sequencing COVID-positive samples at different rates for an average of about five per cent

It’s been a little more than a year since scientists and biotech companies around the world pivoted to understanding, treating and preventing COVID-19. Here are five projects to watch led by experts in Canada:

CanCOGeN

Led by Genome Canada, the Canadian COVID-19 Genomics Network aims to identify, understand and track faster spreading variants, including those first found in the United Kingdom, South Africa and Brazil. Tracking variants involves targeted and some random genomic sequencing of COVID-positive samples to determine if there’s a change in the virus’s genetic blueprint. The network’s executive director, Dr. Catalina Lopez-Correa, said the variants have spurred scientists to track changes to the virus at a speed and scale never seen before.

“Genomic epidemiology is now at the centre of our strategy to understand and control the COVID-19 pandemic,” she said.

The provinces are sequencing COVID-positive samples at different rates for an average of about five per cent across the country, she said. A new federal strategy focused on variants of concern is set to increase data sharing among researchers.

APN01

Data is expected soon from the phase two clinical trial for APN01, a treatment candidate for COVID-19 developed after the outbreak of SARS in 2002. Dr. Josef Penninger, the director of the University of British Columbia’s Life Sciences Institute, was working in Toronto at the time and helped pinpoint the key receptor by which SARS entered and began to replicate in human cells. It turns out the enzyme ACE2 is also the gateway into cells for the new coronavirus, said Penninger, who co-founded Apeiron Biologics.

The Austrian biotech company is now developing APN01 as a “soluble ACE2” therapy or drug to treat COVID-19 patients. It has “dual action,” Penninger said in a news release last fall, meaning it can both block the virus and also protect the lung, blood vessels or heart from injury. In September last year, the Lancet’s peer-reviewed respiratory medicine journal published a case report describing “significant clinical improvement” after APN01 was administered to a patient suffering from severe COVID-19.

Peptide possibilities

At the University of Regina, biochemist Mohan Babu is leading a team of researchers across Canada exploring how peptides – short chains of amino acids that make up proteins – could play a role in both diagnosing and treating COVID-19. They’re working to identify a peptide sequence that points to the illness in asymptomatic, mildly symptomatic and symptomatic patients, Babu explained. Their goal is to lay the foundation for a low-cost rapid test using saliva instead of the standard nasal swab and molecular (PCR) test.

“Those peptide signatures that are highly abundant in your saliva (are) going to be your diagnostic kit,” he said, adding the peptides are more stable and don’t degrade as quickly as the genetic material used in other tests.

On the treatment side, Babu said his team aims to “hijack” the virus using antiviral peptides that block it from entering and replicating inside human cells. They’re using a tiny part of the virus’s own sequence, coaxing it to bind to the ACE2 receptor, he said, while the remainder of the peptide sequence is randomized and the virus’s gateway into cells should wind up destroyed.

The researchers have so far identified four antiviral peptides that appear to inhibit the virus and they’re starting to test against several variants, said Babu. The results of their work have yet to pass through a peer-review process. Babu is receiving more than $900,000 in federal funding through the Canadian Institutes of Health Research for his research on COVID-19.

Blood biomarkers

Immunologists at Dalhousie University in Halifax are working with critical care specialists in Spain to examine key “biomarkers” in the blood of COVID-19 patients, which could help predict the severity of the illness. For a study published in the peer-reviewed journal Critical Care, they tested 250 patients with varying degrees of illness for ribonucleic acid or RNA – the virus’s “genetic blueprint” – and found 78 per cent of those who were severely ill had higher amounts of viral RNA than mild cases.

“We now have an extremely reliable indicator for identifying severe COVID-19 patients who require critical care and should be admitted to the ICU, which will help intensive care unit doctors prioritize severely ill patients,” said David Kelvin, Canada research chair at Dalhousie’s microbiology and immunology department, in a December statement.

The team also linked viral RNA to dysfunctional immune response among COVID-19 patients and they’re now examining how new variants of the virus affect host immunity compared with the first wave of the pandemic, he said. Their work is supported by the Canadian Institutes of Health Research.

Wastewater testing

Testing for COVID-19 in raw wastewater is scaling up in several provinces, including Ontario, B.C. and Nova Scotia. Gail Krantzberg, a professor in the engineering department at Hamilton’s McMaster University, said COVID-19 is “absolutely detectable” in many of the southern Ontario municipalities participating in the project.

A network of researchers at different universities is also working to make the testing more sensitive to detecting the virus. They recently had a sample and couldn’t detect it, but got a signal after refining their methods, said Krantzberg, adding the virus found in wastewater is “deactivated” and no longer live.

The researchers hope to use wastewater to sound the alarm about potential clusters in real time, before new individual cases are found, she said.

“People who are asymptomatic may not get tested. They’re walking around, they’re sick (and) nobody knows, even though they’re excreting (the virus).”

They should soon be able to deliver test results to health officials three times a week within 24 hours of sampling, said Krantzberg.

Brenna Owen, The Canadian Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta Health reported two new COVID-19 deaths in Red Deer Friday. (Image courtesy CDC)
Two more deaths linked to Olymel outbreak in Red Deer

Province reported 356 additional COVID-19 cases Friday

Alberta Premier Jason Kenney speaks during a news conference in Edmonton on Feb. 24, 2020. It’s budget day in the province, and Kenney’s United Conservative government is promising more help in the fight against COVID, but more red ink on the bottom line. THE CANADIAN PRESS/Jason Franson
Alberta’s budget promises more help for COVID-19 with a hard deficit

Annual spending on debt interest is closing in on $3 billion

Alberta reported an additional 399 cases of COVID-19 Thursday, on 9,217 tests, for a test positivity rate of 4.3 per cent. (Image courtesy CDC)
Red Deer down to 562 active COVID-19 cases

8 new COVID-19 deaths, 399 additional COVID-19 cases

(File photo/Lauren Collins Vana)
Ponoka cat owners have until July 1, 2021 to purchase licenses

Town council passed new Animal Control Bylaw Feb. 23

City of Red Deer has nearly doubled its active COVID-19 case count since Feb. 10 and has 75.6 per cent of the Central zone’s active cases. (File photo)
Another new high: Red Deer hits 574 active COVID-19 cases

Province reports 13 new COVID-19 deaths, 430 new cases

Bookings for COVID-19 vaccines for people age 75 or older start Wednesday. (File photo by THE CANADIAN PRESS)
Updated: Delays for seniors booking for vaccine appointments

By 9:20 a.m. Wednesday, 4,500 seniors had booked their appointments

A helicopter flies past a mountain near McBride, B.C., on Saturday January 30, 2016. THE CANADIAN PRESS/Darryl Dyck
Avalanche warning for backcountry users in North and South Rockies

Avalanche Canada is urging backcountry users to always check their regional avalanche forecasts

Supporters pray outside court in Stony Plain, Alta., on Wednesday, Feb. 24, 2021, as a trial date was set for Pastor James Coates of GraceLife Church. He is charged with holding Sunday services in violation of Alberta’s COVID-19 rules and with breaking conditions of his bail release. THE CANADIAN PRESS/Jason Franson
Trial date for jailed Alberta pastor charged with breaking COVID-19 health orders

The court says it will reconvene with lawyers on March 5 for a case management plan by teleconference

A pharmacist prepares a COVID-19 vaccine at Village Green Retirement Campus in Federal Way on Jan. 26. (Olivia Sullivan/Sound Publishing)
Canada approves use of AstraZeneca’s COVID-19 vaccine

The country joins more than a dozen others in giving the shot the green light

Emily Keeping of Wetaskiwin, Alta., was last seen at 4:20 p.m. on Feb. 25, 2021 at the FasGas on 49 St and 50 Ave in Wetaskiwin. Supplied/ Wetaskiwin RCMP.
UPDATE: Wetaskiwin RCMP seek assistance in locating missing 11-year-old

Emily Keeping was last seen on Feb. 25, 2021 at the FasGas on 49 St and 50 Ave in Wetaskiwin.

Sylvan Lake's Winter Village lured many visitors to the town this winter. The town has launched a new contest to attract a new business.
(Black Press file photo)
Sylvan Lake offering rent-free storefront space to lure new businesses

Winning business proposal will get a storefront space rent-free for a year

Alberta premier Jason Kenney, right and Doug Schweitzer, Minister of Justice and Solicitor General, provide details about Bill 13, the Alberta Senate Election Act., in Edmonton Alta, on Wednesday June 26, 2019. THE CANADIAN PRESS/Jason Franson
Minister Doug Schweitzer talks on Enhanced COVID-19 Business Benefit

Provincial government rolling out new benefit this April to better help small businesses.

NDP leader Jagmeet Singh holds a press conference on Parliament Hill in Ottawa on Wednesday, Feb. 24, 2021. THE CANADIAN PRESS/Sean Kilpatrick
NDP will not trigger election as long as pandemic continues: Singh

‘“We will vote to keep the government going’

Mike Ammeter (Photo by Rebecca Hadfield)
Sylvan Lake man elected chair of Canadian Canola Growers Association

Mike Ammeter is a local farmer located near the Town of Sylvan Lake

Most Read